Literature DB >> 7332350

Presence of eosinophilia in progressive systemic sclerosis and localized scleroderma.

M Giordano, M Ara, G Valentini, U Chianese, T Bencivenga.   

Abstract

Recent studies on eosinophilic fasciitis have lead to this investigation of eosinophilia in progressive systemic sclerosis and localized scleroderma. Eosinophilia (eosinophilic count greater than 300/cmm) was found in ten of 63 progressive systemic sclerosis patients (15.8%) and in two of nine localized scleroderma cases (22.2%). In patients with progressive systemic sclerosis eosinophilia was found occasionally in six cases; it was transitory, but frequent in three cases; it was constant and very high in one case. In patients with localized scleroderma eosinophilia was found occasionally in one case and frequent, but not constant, in the other one. The possible influence of drugs could be excluded in five cases: three progressive systemic sclerosis cases and two affected with localized scleroderma. Therefore, it is possible to confirm that eosinophilia is not a distinctive sign of eosinophilic fasciitis in patients suffering from scleroderma-like syndromes. While eosinophilia is related to inflammation in eosinophilic faciitis, eosinophilia and disease activity could not be correlated in our patients with PSS. Recently, it has been suggested that eosinophilia might be an unfavorable prognostic criterion in progressive systemic sclerosis. Our data does not allow confirmation of this assumption.

Entities:  

Mesh:

Year:  1981        PMID: 7332350     DOI: 10.1007/bf00406686

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  17 in total

1.  Scleroderma; based on a study of over 150 cases.

Authors:  I LEINWAND; A W DURYEE; M N RICHTER
Journal:  Ann Intern Med       Date:  1954-11       Impact factor: 25.391

2.  Diffuse fasciitis with eosinophilia: a new syndrome?

Authors:  L E Shulman
Journal:  Trans Assoc Am Physicians       Date:  1975

Review 3.  Eosinophil function related to cutaneous disorders.

Authors:  D Zucker-Franklin
Journal:  J Invest Dermatol       Date:  1978-07       Impact factor: 8.551

4.  [Differential blood pictures in progressive and circumscribed scleroderma].

Authors:  H Roder; B Pinzer
Journal:  Dermatol Monatsschr       Date:  1972-06

5.  [Shulman's syndrome: fasciitis with eosinophilia, pseudoscleroderma with eosinophilia].

Authors:  J Chevrant-Breton; M Mondaud; O Sabouraud; A Huguenin
Journal:  Ann Dermatol Venereol       Date:  1977-10       Impact factor: 0.777

6.  The heart in scleroderma.

Authors:  M A Sackner; E R Heinz; A J Steinberg
Journal:  Am J Cardiol       Date:  1966-04       Impact factor: 2.778

7.  [Eosinophilic fasciitis. A recently reported oligotopic connective tissue inflammation. A case report].

Authors:  M Giordano; M Ara; R Rossiello; C Cicala; G Valentini
Journal:  Z Rheumatol       Date:  1980 Jul-Aug       Impact factor: 1.372

8.  Diffuse fasciitis with hypergammaglobulinemia and eosinophilia: a new syndrome?

Authors:  L E Shulman
Journal:  J Rheumatol       Date:  1984-10       Impact factor: 4.666

9.  Scleroderma, eosinophilia, and diffuse fasciitis.

Authors:  R Fleischmajer; A B Jacotot; S Shore; S A Binnick
Journal:  Arch Dermatol       Date:  1978-09

10.  Progressive systemic sclerosis with eosinophilia and a fulminating course.

Authors:  I J Don; U Khettry; J J Canoso
Journal:  Am J Med       Date:  1978-08       Impact factor: 4.965

View more
  2 in total

1.  Massive eosinophilia in rheumatoid arthritis: report of four cases.

Authors:  P T Dawes; D H Smith; D L Scott
Journal:  Clin Rheumatol       Date:  1986-01       Impact factor: 2.980

Review 2.  Eosinophilia predicts poor clinical outcomes in recent-onset arthritis: results from the ESPOIR cohort.

Authors:  Dewi Guellec; Morgane Milin; Divi Cornec; Gabriel J Tobon; Thierry Marhadour; Sandrine Jousse-Joulin; Gilles Chiocchia; Olivier Vittecocq; Valérie Devauchelle-Pensec; Alain Saraux
Journal:  RMD Open       Date:  2015-07-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.